Page last updated: 2024-08-25

beta-hydroxyisovaleric acid and Impaired Glucose Tolerance

beta-hydroxyisovaleric acid has been researched along with Impaired Glucose Tolerance in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Awady, MS; Gameil, NM; Megahed, N; Sharawy, MH	1

Other Studies

1 other study(ies) available for beta-hydroxyisovaleric acid and Impaired Glucose Tolerance

Article	Year
The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver. Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:5 Topics: Animals; Dietary Carbohydrates; Dietary Supplements; Endothelium, Vascular; Fructose; Gene Expression Regulation; Glucose Intolerance; Glucose Transporter Type 2; Hyperinsulinism; Hyperlipidemias; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Performance-Enhancing Substances; PPAR alpha; Random Allocation; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Valerates; Vascular Resistance	2016

Article

Year

The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver.

Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:5

Topics: Animals; Dietary Carbohydrates; Dietary Supplements; Endothelium, Vascular; Fructose; Gene Expression Regulation; Glucose Intolerance; Glucose Transporter Type 2; Hyperinsulinism; Hyperlipidemias; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Performance-Enhancing Substances; PPAR alpha; Random Allocation; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Valerates; Vascular Resistance

2016